Get started
Author

Caterina Riillo

Observed names: C Riillo, C. Riillo, RIILLO, CATERINA, Riillo, Caterina
ORCID: 0000-0002-7983-5099
Observed ORCID: 0000-0002-7983-5099
OpenAlex ID: A5060158728
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
2020 · Katia Grillone, Caterina Riillo, et al. · Journal of Experimental & Clinical Cancer Research · 258
PDF
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
2022 · Maria Teresa Di Martino, Mariamena Arbitrio, et al. · Molecular Therapy — Nucleic Acids · 162
PDF
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
2020 · Cristina Perez, Cirino Botta, et al. · Blood · 154
PDF
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
2021 · Maria Teresa Di Martino, Caterina Riillo, et al. · Cancers · 100
PDF
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study
2023 · Pierfrancesco Tassone, Maria Teresa Di Martino, et al. · Journal of Hematology & Oncology · 90
PDF
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ Heel
2021 · Daniele Caracciolo, Caterina Riillo, et al. · Cancers · 90
PDF
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
2017 · C Botta, M Cucè, et al. · Leukemia · 67
PDF
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma
2020 · Daniele Caracciolo, Francesca Scionti, et al. · Haematologica · 50
PDF
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma
2020 · Marco Rossi, Emanuela Altomare, et al. · Leukemia · 48
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
2019 · Maria Cucè, Maria Eugenia Gallo Cantafio, et al. · Journal of Hematology & Oncology · 46
PDF
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis
2022 · M.A. Siciliano, G. Caridà, et al. · ESMO Open · 44
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling
2020 · Mario Russo, Luca Tirinato, et al. · ACS Omega · 39
PDF
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives
2023 · Daniele Caracciolo, Antonia Mancuso, et al. · Experimental Hematology and Oncology · 38
PDF
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma
2022 · Katia Grillone, Caterina Riillo, et al. · International Journal of Molecular Sciences · 37
PDF
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
2021 · Daniele Caracciolo, Caterina Riillo, et al. · Cancers · 32
PDF
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma
2024 · Katia Grillone, Serena Ascrizzi, et al. · Blood · 29
PDF
Error‐prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment
2020 · Daniele Caracciolo, Caterina Riillo, et al. · International Journal of Cancer · 29
PDF
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
2021 · Daniele Caracciolo, Caterina Riillo, et al. · Journal for ImmunoTherapy of Cancer · 26
PDF
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
2023 · Patricia Hernández-López, Eline van Diest, et al. · Nature Immunology · 25
Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy
2025 · Dennis X. Beringer, Trudy Straetemans, et al. · Nature reviews. Cancer · 23
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma
2023 · Francesca Scionti, Giada Juli, et al. · Journal of Experimental & Clinical Cancer Research · 21
PDF
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells
2022 · Caterina Riillo, Daniele Caracciolo, et al. · Cancers · 19
PDF
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
2022 · Francesca Scionti, Giuseppe Agapito, et al. · Cells · 17
PDF
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis
2023 · Domenico Ciliberto, Giulio Caridà, et al. · Heliyon · 11
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis
2023 · Nicoletta Staropoli, Domenico Ciliberto, et al. · Critical Reviews in Oncology/Hematology · 9
Works count: 67
Citation count: 1,512
H-index: 21
I10-index: 24
Year
Topic
Type